Live Breaking News & Updates on Guru Harikrishn Foundation

Stay updated with breaking news from Guru harikrishn foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Business News | Fundamentals of the Recently Launched Cervical Cancer Vaccine by Art of Healing Cancer

Get latest articles and stories on Business at LatestLY. Cervical cancer is the fifth most common cancer among women globally according to World Health Organization (WHO). India accounts for one-fifth (1/5th) of the global burden of the disease. Every year in India, approximately 1.23 lakh women are diagnosed with cervical cancer and around 67,000 die from the disease. It is the second most common cancer affecting women in India. India has a population of approximately 43 crores women aged 15 years and older who are at risk of developing cervical cancer. Business News | Fundamentals of the Recently Launched Cervical Cancer Vaccine by Art of Healing Cancer. ....

United States , Gurugram Haryana , Manjit Singh , Gardasil Merck , Amandeep Singh Malhotra , Arpan Talwar Co , National Immunization Program , Guru Harikrishn Foundation , World Health Organization , Serum Institute Of India , Businesswire India , Clinical Lead , Chief Mentor , Healing Cancer , Surgical Oncologist , Papilloma Virus , Sonal Jain , Human Papillomavirus Quadrivalent , Serum Institute , Drugs Controller General ,

Fundamentals of the recently launched cervical cancer vaccine by Art of Healing Cancer

Gurugram (Haryana) [India], September 13 (ANI/BusinessWire India): Cervical cancer is the fifth most common cancer among women globally according to World Health Organization (WHO). India accounts for one-fifth (1/5th) of the global burden of the disease. Every year in India, approximately 1.23 lakh women are diagnosed with cervical cancer and around 67,000 die from the disease. It is the second most common cancer affecting women in India. India has a population of approximately 43 crores women aged 15 years and older who are at risk of developing cervical cancer. According to Dr Mandeep Singh Malhotra (Clinical Lead and Chief Mentor, Art of Healing Cancer [AOHC- www.artofhealingcancer.com]); Surgical Oncologist, "Human Papilloma Virus (HPV) prevalence among cervical cancer patients in India has varied from 87.8 per cent to 96.67 per cent. HPV is key element and a primary reason for the development of cervical cancer. Therefore, preventing HPV infection can prevent the majority of ....

United States , Gurugram Haryana , Manjit Singh , Gardasil Merck , Amandeep Singh Malhotra , Arpan Talwar Co , National Immunization Program , Guru Harikrishn Foundation , World Health Organization , Serum Institute Of India , Businesswire India , Clinical Lead , Chief Mentor , Healing Cancer , Surgical Oncologist , Papilloma Virus , Sonal Jain , Human Papillomavirus Quadrivalent , Serum Institute , Drugs Controller General , Gurugram Haryana India , Eptember 13 Ani Businesswire India Cervical Cancer Is The Fifth Most Common Among Women Globally According To World Health Organization Who Accounts For One 1 5th Of Global Burden Disease Every Year In , Pproximately 1 23 Lakh Women Are Diagnosed With Cervical Cancer And Around 67 , 000 Die From The Disease It Is Second Most Common Cancer Affecting Women In India Hasa Population Of Approximately 43 Crores Aged 15 Years And Older Who Are At Risk Developing Cervical According To Dr Mandeep Singh Malhotra Clinical Lead Chief Mentor , Rt Of Healing Cancer Aohc Www Artofhealingcancer Com Surgical Oncologist , Uot Human Papilloma Virus Hpv Prevalence Among Cervical Cancer Patients In India Has Varied From 87 8 Per Cent To 96 67 Is Key Element Anda Primary Reason For The Development Of Therefore ,

Cancer related Anemia should be treated on priority, suggests Doctors at Art of Healing Cancer

Gurgaon (Haryana) [India], September 6 (ANI/BusinessWire India): Anemia is a condition that affects more than half of cancer patients at diagnosis and during treatment which further impacts their quality of life on an everyday basis. Cancer patients with anemia show reduced response to radiotherapy and chemotherapy due to tumor hypoxia cause by anemia. This condition is further associated with aggressive tumor growth and metastasis. Thus, anemia in a patient who is battling with cancer needs attention and appropriate treatment. According to Dr Sonal Jain - MD, Art of Healing Cancer (AOHC), Hematopathologist DM AIIMS, "Right Treatment begins with Right Diagnosis. A battery of tests (Complete blood count with peripheral smear, Iron Profile, Vitamin B12/ folate levels, Serum LDH, Coomb's test etc.) can help in picking up patients with treatable cause of low hemoglobin or Anemia. If these are not the reasons, patients can then be treated judiciously with Erythropoiesis Stimulating ....

Gurgaon Haryana , Anemia Panel , Arpan Talwar Co , Guru Harikrishn Foundation , Manjit Singh Co , Art Of Healing Cancer Initiative , Businesswire India , Healing Cancer , Iron Profile , Erythropoiesis Stimulating Agents , Healing Cancer Initiative , Arpan Talwar , Comprehensive Anemia Panel , Manjit Singh , Gurgaon Haryana India , Eptember 6 Ani Businesswire India Anemia Isa Condition That Affects More Than Half Of Cancer Patients At Diagnosis And During Treatment Which Further Impacts Their Quality Life On An Everyday Basis With Show Reduced Response To Radiotherapy Chemotherapy Due Tumor Hypoxia Cause By This Is Associated Aggressive Growth Metastasis Thus , Nemia Ina Patient Who Is Battling With Cancer Needs Attention And Appropriate Treatment According To Dr Sonal Jain Md , Rt Of Healing Cancer Aohc , Ematopathologist Dm Aiims , Uot Right Treatment Begins With Diagnosisa Battery Of Tests Complete Blood Count Peripheral Smear , Iron Profile , Itamin B12 Folate Levels , Erum Ldh , Oomb 39s Test Etc Can Help In Picking Up Patients With Treatable Cause Of Low Hemoglobin Or Anemia If These Are Not The Reasons , Atients Can Then Be Treated Judiciously With Erythropoiesis Stimulating Agents Erythropoietin , Arbepoetin Etc Also Called As Esa ,